miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection by Souza, Marina de Assis et al.
This is a repository copy of miR-548d-3p Alters Parasite Growth and Inflammation in 
Leishmania (Viannia) braziliensis Infection.




Souza, Marina de Assis, Ramos-Sanchez, Eduardo Milton, Muxel, Sandra Márcia et al. (8 
more authors) (2021) miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania






This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
miR-548d-3p Alters Parasite Growth
and Inflammation in Leishmania
(Viannia) braziliensis Infection
Marina de Assis Souza1, Eduardo Milton Ramos-Sanchez1,2, Sandra Márcia Muxel3,
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Maria Edileuza Felinto Brito5, Ricardo Andrade Zampieri3, Paul Martin Kaye4,
Lucile Maria Floeter-Winter3 and Hiro Goto1,6*
1 Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (IMTSP/USP), São Paulo, Brazil,
2 Departamento de Salud Publica, Facultad de Ciencias de La Salud, Universidad Nacional Toribio Rodriguez de Mendoza
de Amazonas, Chachapoyas, Peru, 3 Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil, 4 York
Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom, 5 Instituto Aggeu
Magalhães, Fundação Oswaldo Cruz (IAM/FIOCRUZ), Recife, Brazil, 6 Departamento de Medicina Preventiva, Faculdade de
Medicina, Universidade de São Paulo, São Paulo, Brazil
American Tegumentary Leishmaniasis (ATL) is an endemic disease in Latin America,
mainly caused in Brazil by Leishmania (Viannia) braziliensis. Clinical manifestations vary
from mild, localized cutaneous leishmaniasis (CL) to aggressive mucosal disease. The
host immune response strongly determines the outcome of infection and pattern of
disease. However, the pathogenesis of ATL is not well understood, and host microRNAs
(miRNAs) may have a role in this context. In the present study, miRNAs were quantified
using qPCR arrays in human monocytic THP-1 cells infected in vitrowith L. (V.) braziliensis
promastigotes and in plasma from patients with ATL, focusing on inflammatory response-
specific miRNAs. Patients with active or self-healed cutaneous leishmaniasis patients, with
confirmed parasitological or immunological diagnosis, were compared with healthy
controls. Computational target prediction of significantly-altered miRNAs from in vitro
L. (V.) braziliensis-infected THP-1 cells revealed predicted targets involved in diverse
pathways, including chemokine signaling, inflammatory, cellular proliferation, and tissue
repair processes. In plasma, we observed distinct miRNA expression in patients with self-
healed and active lesions compared with healthy controls. Some miRNAs dysregulated
during THP-1 in vitro infection were also found in plasma from self-healed patients,
including miR-548d-3p, which was upregulated in infected THP-1 cells and in plasma
from self-healed patients. As miR-548d-3p was predicted to target the chemokine
pathway and inflammation is a central to the pathogenesis of ATL, we evaluated the
effect of transient transfection of a miR-548d-3p inhibitor on L. (V.) braziliensis infected-
THP-1 cells. Inhibition of miR-548d-3p reduced parasite growth early after infection and
increased production of MCP1/CCL2, RANTES/CCL5, and IP10/CXCL10. In plasma of
self-healed patients, MCP1/CCL2, RANTES/CCL5, and IL-8/CXCL8 concentrations were
significantly decreased and MIG/CXCL9 and IP-10/CXCL10 increased compared
to patients with active disease. These data suggest that by modulating miRNAs,
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L. (V.) braziliensis may interfere with chemokine production and hence the inflammatory
processes underpinning lesion resolution. Our data suggest miR-548d-3p could be
further evaluated as a prognostic marker for ATL and/or as a host-directed
therapeutic target.
Keywords: Leishmania braziliensis, microRNA, pathogenesis, active cutaneous leishmaniasis, self-healed
cutaneous leishmaniasis, THP-1 cells
INTRODUCTION
The leishmaniases are vector-borne diseases caused by protozoan
parasites of the genus Leishmania. Transmitted by Phlebotomine
sandflies, the leishmaniases are endemic in tropical and
subtropical areas, with one million cases/year in 98 countries
(Burza et al., 2018). During its life cycle, Leishmania exists as
promastigotes (elongated forms with an external flagellum) in
the sandfly gut and as amastigotes (round or ovoid forms without
an external flagellum) within mononuclear phagocytes of the
vertebrate host. After promastigote inoculation in the skin by
the vector, the parasites interact primarily with tissue humoral and
cellular elements and the infection may progress to overt disease.
Depending on the Leishmania species and host characteristics, the
disease may manifest as visceral leishmaniasis, affecting organs,
such as the liver and spleen, or tegumentary form, causing lesions
in the skin and mucosa. More than 15 species may cause
cutaneous leishmaniasis, with Leishmania (Viannia) braziliensis
the most prevalent species in Brazil, where disease presents as
either localized cutaneous leishmaniasis (CL), disseminated
cutaneous leishmaniasis, or disfiguring mucosal leishmaniases
(Turetz et al., 2002; Machado et al., 2011; Goto and Lauletta
Lindoso, 2012). Once diagnosed, most patients are treated with
anti-Leishmania drugs but rarely the patients heal without any
specific treatment. Comparing active cutaneous and self-healed
leishmaniasis patients constitutes a unique opportunity to explore
pathogenic mechanisms of lesion development and control that
are not fully elucidated.
In human CL, lesion development is not directly related to
parasite growth, and few parasites are seen in the skin (Sotto et al.,
1989). Instead, Th-1-type immune responses essential for infection
control also drive inflammation and lesion development and cause
tissue damage if uncontrolled (Vieira et al., 2002). In CL lesions
characterized by chronic inflammation, activated CD69+ T cells
(Diaz et al., 2002) and regulatory CD4+CD25+FOXP3+ IL-10–
producing T cells, granzyme A CD8+ cytotoxic T cells, or even
pro-inflammatory CD4+ IFN-g–producing T cells (Bourreau et al.,
2009; Faria et al., 2009) have all been observed. In a recent
transcriptomic study of skin samples of cutaneous leishmaniasis
patients, delayed or absence of cure was correlated with higher
expression of gene sets related to the cytolytic pathway, including
mRNAs for granzyme (GZMB), perforin (PRF1), and granulysin
(GNLY) (Amorim et al., 2019).
microRNAs (miRNAs), endogenous small non-coding RNAs
of ~22 nucleotides, have a fundamental role in shaping the host
transcriptome (Baltimore et al., 2008) and act as key regulators in
gene expression networks, including those regulating cell cycle,
mitosis, apoptosis, differentiation, and immune functions.
MicroRNAs mediate gene silencing post-transcriptionally by
base-pairing to the 3′-untranslated regions (3’UTR) of their
respective target genes. Up/down-regulation of miRNA
expression impacts various cellular processes during homeostasis
but may also result in dysfunction of cellular activities (Bartel,
2004; Bartel, 2009) and participate in pathological processes
including infection and inflammation (O’Connell et al., 2012).
In the human immune system, miRNA-clusters have been shown
to exert essential roles in the regulation of related gene expression,
impacting innate and adaptive immune responses (Hirschberger
et al., 2018). Furthermore, as most miRNAs are considered stable
in biological fluids and resistant to environmental conditions
(Sohel, 2016), miRNAs are suitable for evaluation in plasma
samples and represent attractive candidates as biomarkers of
disease or therapeutic response.
MicroRNAs can be modulated by different pathogens, such as
viruses, bacteria, and protozoan parasites (Chandan et al., 2019;
Acuna et al., 2020). Differential expression of diverse miRNA has
been identified in Leishmania-host interaction in vitro and
experimental in vivo systems with visceral and cutaneous
strains of Leishmania (Acuna et al., 2020) as well as human
leishmaniasis (Paul et al., 2020). Specifically, in cutaneous
leishmaniasis caused by L. braziliensis miR-361-3p, a regulator
of GZMB and tumor necrosis factor (TNF) was down-regulated
and related to treatment failure (Lago et al., 2018). In contrast,
expression of miR-193b and miR-67, involved in regulating
expression of triggering receptor expressed on myeloid cells-1
(TREM-1) was positively related to good treatment outcome
(Nunes et al., 2018).
In the present study, we searched for differentially expressed
microRNA in plasma of patients with active L. (V.) braziliensis
infection and self-healed CL patients. In addition, we studied in
vitro L. (V.) braziliensis infected-human monocyte-derived THP-1
cells to provide more direct insights into miRNA function. We
focused on miRNA related to immune-inflammatory processes
given the role of such processes in CL lesion development and
resolution. miRNA expression was found to be markedly different
between patients with self-healed leishmaniasis compared to
healthy controls and cases with active CL. Among various
differentially expressed miRNAs in patient plasma and
L. braziliensis-infected THP-1 cells, we selected miR-548d-3p
that was upregulated in both settings for further validation.
MiR-548d-3p inhibition in THP-1 cells reduced early parasite
growth and increased MCP1/CCL2, RANTES/CCL5, and IP-10/
CXCL10, whereas in self-healed patients, MCP1/CCL2, RANTES/
CXCL5, and IL-8/CXCL8 were decreased, and MIG/CXCL9 and
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IP-10/CXCL10 were increased compared with active cases.
Collectively, these data suggest that L. (V.) braziliensis exploits
miRNAs to modulate the production of discrete sets of pro-
inflammatory cytokines that are involved in lesion resolution.
MATERIALS AND METHODS
Ethics Statement
The experimental protocols were approved by the ethics
committee of the Faculdade de Medicina, Universidade de São
Paulo (CAAE 35670314.0.1001.0065) and are in the accordance
with the World Medical Association Declaration of Helsinki on
Ethical Principles for Medical Research lnvolving Human Subjects
of 1964 with latest amendment of 2013. All individuals agreed to
participate by signing the Informed Consent Form.
Patients
Individuals of both gender and age from 15 to 60 years old were
selected from endemic areas in Pernambuco state, Northeastern
Brazil where L. (V.) braziliensis is the predominant species
causing CL. Five patients with active disease were chosen based
on the presence of up to five cutaneous lesions, confirmed
diagnosis of leishmaniasis and absence of local concomitant
bacterial infections, comorbidities such as HIV/aids, diabetes
mellitus, dermatitis, peripheral vascular diseases, and previous
chemotherapy. The diagnosis of active cases was confirmed by
submitting sample to direct microscopic parasitological exam of
lesion scrapings, by culture, by inoculation into hamsters for
parasitological recovery or by polymerase chain reaction specific
for Viannia subgenus (Brito et al., 2009).
Five self-healed patients with a history of previous cutaneous
leishmaniasis were also recruited, showing characteristic scars,
confirmed diagnosis, and absence of abovementioned
comorbidities, co-infections, and previous chemotherapy.
Another five healthy individuals represented the control group,
being recruited from non-endemic areas and without previous
leishmaniasis, abovementioned comorbidities, or co-infections.
The patients with active or self-healed leishmaniases were
from the municipalities of Paudalho, Moreno, Jaboatão, and
Bezerros, localities close by preserved remnants of Atlantic
forest, in the State of Pernambuco, Northeast Brazil, where
intertwine rural and urban environments where they live and
work (Figure 1).
After confirmed diagnosis, four milliliters of whole blood
were collected in EDTA from each individual, and plasma stored
at −80°C until use.
Parasites
Leishmania parasites were previously isolated from a patient
with mucosal leishmaniasis at Corte de Pedra, Bahia, Brazil, and
characterized as L. (V.) braziliensis by the Leishmania Collection
at Fundação Oswaldo Cruz—CLIOC/FIOCRUZ. To preserve the
infectivity, the parasites were inoculated via intraperitoneal route
and maintained through regular passages in hamster
(Mesocricetus auratus). Amastigotes were then purified from
the spleen of hamster and expanded in axenic culture with
Schneider’s insect medium (Sigma-Aldrich, USA) containing
100 UI/ml penicilin and 100 mg/ml streptomycin and
supplemented with 10% heat-inactivated fetal calf serum (FCS)
(Cultilab, Brazil) at 26°C. The amastigote-derived promastigotes
were cryopreserved in aliquots and thawed for use in specific
experiments. Promastigotes were cultured in Schneider’s insect
medium (Sigma-Aldrich, USA) containing 100 UI/ml penicilin
and 100 mg/ml streptomycin and supplemented with 10% heat-
inactivated fetal calf serum (FCS) (Cultilab, Brazil) at 26°C. The
parasites used in the experiments were at the stationary phase of
growth and with no more than four passages in culture.
Infection of Macrophages With
L. (V.) braziliensis
THP-1 monocytic cell line (ATCC) was maintained in RPMI 1640
medium (Sigma-Aldrich, USA) supplemented with 2 mM L-
glutamine, 1 mM sodium piruvate, 0.2% sodium bicarbonate,
and 5% FCS (complete medium). Then 106 cells in 1 ml of
RPMI 1640 medium were plated onto 24-well plates (Costar,
USA) and incubated in the presence of 20 ng/ml phorbol myristate
acetate (PMA; Sigma-Aldrich, USA) for 48 h at 37°C in a humid
atmosphere with 5% CO2 to allow differentiation into
macrophages (Tsuchiya et al., 1982). In experiments for parasite
load analysis, round coverslips were placed in the well. Non-
adherent cells were then removed and L. (V.) braziliensis
FIGURE 1 | Cartographical representation of the State of Pernambuco, Northeastern Brazil. Regions in blue indicate Moreno (1), Jaboatão (2), Paudalho (3), and
Bezerros (4) municipalities.
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promastigotes were added to the wells in triplicates (parasite:cell
ratio = 5:1) and incubated for 4 h at 33°C in humid atmosphere
with 5% CO2 to allow infection of macrophages. Non-infected
cells were maintained only with culture medium, being the
negative control of the experiment. After washing out the non-
internalized parasites, complete RPMI medium was added to the
wells, beginning the experimental period (0 h). The plates were
then maintained for 6 or 24 h at 37°C in a humid atmosphere with
5% CO2.
Evaluation of Parasite Load
in Macrophages
Glass coverslips were removed from the wells and stained with
panoptic dyes (Instant Newprov, Brazil) and mounted on glass
slides for evaluation of parasitism. A total of 900 cells were
counted for each experimental condition, 300 cells/coverslip,
under light microscope (Carl Zeiss, Germany), and the number
of parasites per 100 cells calculated as [(number of parasites/
number of infected cells) × (number of infected cells/total
number of cells) × 100].
RNA Extraction, Reverse Transcription,
and Pre-Amplification
Total RNA extraction from adherent THP-1 cells was performed
using the miRVana PARIS isolation kit (Thermo Fisher, USA),
according to the manufacturer’s instructions, and RNA integrity
was determined in spectrophotometer as an OD260/280
absorption ratio between 1.8 and 2.1. The total RNA
purification in plasma samples was performed using the
miRNeasy Serum/Plasma kit (Qiagen, USA), with the addition
of a spike-in control (Caenorhabditis elegans cel-miR-39) to
ensure the quality of the procedure and to allow qPCR
normalization, according to the manufacturer’s instructions.
Complementary DNA (cDNA) to template RNA purified from
THP-1 cells and plasma samples was synthesized with miScript
II RT kit (Qiagen, USA). Briefly, 250 ng of total RNA from THP-
1 cells were added to 2 ml of 5× miScript HiSpec Buffer, 1 ml of
10× Nucleics Mix, and 1 ml of miScript Reverse Transcriptase
Mix. RNase-free water was added to a final volume of 10 ml. The
RNA was incubated for 60 min at 37°C to insert poly-A tail
downstream of the miRNA sequence and anneal a T-tail tag for
the cDNA elongation. The enzyme was inactivated at 95°C for
5 min. The reaction was performed in the Mastercycler Gradient
thermal cycler (Eppendorf, Germany), and the product was
stored at −20°C until use. The reverse transcription reaction
for plasma samples followed the same protocol, with the
manufacturer’s instructions to add 4.5 µl of the purified total
RNA. Then, 40 µl of DEPC water was added into each 10 µl RT-
PCR product and submitted to a pre-amplification reaction
(preAmp), using the miScript PreAmp PCR Kit (Qiagen, USA)
according to the manufacturer’s instructions. Then the samples
were diluted 10× and stored at −20°C.
Quantitative Real-Time PCR for miRNA
miRNA expression was evaluated with the miScript microRNA
PCR array (Qiagen, USA), focusing on inflammation, and auto-
immunity pathway-related molecules (MIHS-105Z). Ready-to-
use qPCR plates containing a set of 84 specific primers for
miRNAs and 12 internal controls were filled in with the
previously prepared master mix containing PCR Buffer, SYBR
Green, and the 10-fold diluted cDNA for in vitro infected THP-1
macrophages or preAmp samples of plasma samples.
Quantitative PCR conditions were 40 cycles of 94°C for 15 s,
55°C for 30 s, and 70°C for 30 s. Normalization of miRNA
expression in THP-1-derived macrophages was performed using
SNORD95 and RNU6-6p as reference genes amplified in the
qPCR plate. The relative expression levels were calculated using
the Comparative Ct method, with non-infected cells being
considered as the calibrator group.
For plasma samples, miRNA expression was also evaluated by
relative quantification after previous normalization described by
Marabita et al. (2016). The cel-miR-39 spike-in control
was considered as a technical reference. Simultaneously,
a geometric mean of all expressed miRNAs was used as
a normalization factor to calculate relative expression to a
calibrator group, which varied depending on the analysis.
In Silico miRNA Target Prediction
Target prediction strategy was performed in two different
platforms, considering the miRNAs differentially expressed in
the in vitro experiment. For an initial screening in human
leishmaniasis pathway, we used DIANA-miRpath 3.0 server in
the reverse search module (Vlachos et al., 2015), with Targetscan
(Agarwal et al., 2015) as the chosen algorithm. To discover
potential interactions with other biological pathways related to
human leishmaniasis pathogenesis, we performed a second
analysis using MiEAA (MiRNA Enrichment Analysis and
Annotation), which integrates data from different databases
such as miRBase, miRWalk, and miRTarBase (Backes
et al., 2016).
In Vitro miRNA Inhibition
The inhibition of miR-548d-3p in THP-1-derived macrophages
was performed in an in vitro infection experiment through a
transient transfection protocol. Assays with three different
concentrations (3, 10, and 30 nM) of the mirVana® miR-
548d3p inhibitor (Ambion, USA) or mirVana® miRNA Mimic,
scramble Negative Control (Ambion, USA) were performed, and
10 nM concentration was chosen for further use (Figure S1). At
the end of the experiment, the cell viability was evaluated by
Trypan blue exclusion test when viability higher than 95% was
seen in all conditions. Before the addition of L. (V.) braziliensis
promastigotes, a solution containing the miR-548d-3p inhibitor
or the negative control together with 3 ml of FUGENE
transfection reagent (Promega, USA) diluted in 500 ml of
RPMI medium previously incubated for 20 min at room
temperature was added into each well, and maintained for
24 h. Simultaneously, non-transfected cells received only
complete RPMI medium. The experiment continued with
promastigote infection for evaluation of parasitism, and
chemokine levels in supernatants collected and stored at −80°C
until use.
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Evaluation of Chemokine Production
Chemokine quantification in culture supernatants was performed
using CBA – Human Chemokine Kit (BD Biosciences, USA) in
accordance with manufacturer’s instructions. Briefly, 50 µl of
capture beads for MCP1/CCL2, RANTES/CCL5, IL-8/CXCL8,
MIG/CXCL9, and IP10/CXCL10, 50 µl of Detection Reagent, and
50 µl of the studied sample or standardwere added consecutively to
each sample tube and incubated for 3 h at room temperature, in the
dark. Next, the samples were washed with 1ml ofWash buffer, and
centrifuged. After discarding the supernatant, the pellet was
resuspended in 300 µl buffer and analyzed in a FACS LSR
Fortessa flow cytometer (BD Biosciences, USA). Raw data was
then analyzed using FCAP Array software (BD Biosciences, USA).
The detection limits of each chemokine were as follows: 2.7 pg/ml
forMCP1/CCL2, 1.0 pg/ml for RANTES/CCL5, 0.2 pg/ml for IL-8/
CXCL8, 2.5 pg/ml for MIG/CXCL9, and 2.8 pg/ml for
IP10/CXCL10.
Statistical Analysis
Regarding in vitro miRNA expression, statistical analyses were
performed with Qiagen miScript miRNA PCR Array Data Analysis
online software,wheredatawere submitted to an integratedStudent’s
t test under the manufacturer’s recommendation that was applied in
the previous similar work (Muxel et al., 2017). Ex vivo data were also
submitted to Student’s t test, with Bonferroni’s correction, using
Microsoft Excel 365. Parasite load data were analyzed by ANOVA
with Tukey’s post-test, and data from chemokine quantification by
Kruskal-Wallis test with Bonferroni’s correction. The differences
were considered significant when P < 0.05.
RESULTS
miRNA Expression in L. (V.) braziliensis
Promastigote-Infected THP-1 Cells
We evaluated miRNA expression at 6 and 24 h post infection
with L. (V.) braziliensis promastigotes, considering non-infected
THP-1 cells as the calibrator group. 19 out of 84 miRNAs
presented significant alteration in expression (P < 0.05). At 6 h
p.i., seven miRNAs were upregulated while five were down-
regulated (Figure 2A). In contrast, eight miRNAs were up
regulated in 24 h (Figure 2B). From these results, we observed
that these miRNAs expression was modulated through time and
classified them into four groups. MiR-106b-5p, miR-29b-3p,
and miR-29c-3p were the down-regulated molecules at both 6
and 24 h, while miR-195-5p, miR-30a-5p, and miR-340-5p were
up-regulated at 6 h and down-regulated at 24 h. There were also
down-regulated miRNAs at 6 h and upregulated at 24 h, such as
miR-130a-3p, miR-211-5p, miR-520d-3p, and miR-545-3p,
whereas let7i-5p, miR-30e-5p, miR-302a-3p, miR-302b-3p,
A B
C
FIGURE 2 | miRNA profiles of L. braziliensis infected THP-1-macrophages. Volcano plot of differential expression of miRNA in L. (V.) braziliensis promastigote-
infected THP-1 macrophages in relation to non-infected cells at 6 h (A) and 24 h (B) post-infection compared to uninfected-macrophages. Each dot represents one
miRNA. Red dots indicate the up-regulated miRNAs, and the blue dots represent the down-regulated miRNAs (P < 0.05). Black dotted line corresponds to p = 0.05,
log 10. The relative up- and down-regulation of miRNAs, expressed as boundaries of 2 or -2 of Fold Regulation, respectively. P-value was determined based on two-
tailed Student’s t test. Significantly expressed miRNAs in different times distributed in four groups (C). Experiments were repeated three times.
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miR-34c-5p, miR-372-3p, miR-381-3p, miR-548d-3p, and miR-
875-5p were upregulated at both time-points (Figure 2C).
miRNA Profiling of Serum From
ATL Patients
The participants of this study were predominantly male and the
active disease patients were younger (mean 20 and median 20
years old, minimum-maximum:18-22 ya) than self-healed
patients (mean 26.2 and median 27 years old, minimum-
maximum: 21-30 ya). The number of present or past lesions,
and their localization were similar in both groups. The patients
with active disease presented lesions characteristic of the
localized form of CL (rounded, ulcerated, with well-defined
and elevated edges and granulomatous bottom) on uncovered
parts of the body, with evolution ranging from 15 to 28 days. The
self-healed individuals presented typical scars without previous
anti-Leishmania chemotherapy, with healing time ranging from
three to nine months (Table 1).
The miRNA expression in plasma samples of patients with
active diseasewasnot significantlydifferent compared to the control
group (Figure 3A). In contrast, self-healed individuals presented 14
differentially expressedmiRNAs, eight of them up-regulated (miR-
15b-3p,miR-29b-3p, miR-181-5p,miR-202-3p,miR-211-5p, miR-
302c-5p, miR-373-3p, miR-449-5p), and six down-regulated
(miR-19b-3p, miR-21-5p, miR-29c-3p, miR-30e-5p, miR-656-3p,
miR-93-5p) in relation to the control group (Figure 3B). When
comparing self-healed patients with the active disease group, we
founda total of23 significantlyalteredmiRNAs,with14of theseup-
regulated (miR-15b-5p, miR-20b-5p, miR-29b-3p, miR-181a-5p,
miR-181d-3p, miR-202-3p, miR-211-5p, miR-300, 302c-5p, miR-
410-3p, miR-548d-3p, miR-875-3p, miR-655-3p, miR-1324), and
nine down-regulated (miR-16-5p, miR-17-5p, miR-19b-3p, miR-
21-5p, miR-29c-3p, miR-30e-5p, miR-93-5p, miR-454-3p, miR-
656-3p) (Figure 3C). Our data suggest distinct miRNA profiles in
plasma samples of active and self-healed ATL patients.
Concomitant Altered Expression
of miRNAs in In Vitro and
Ex Vivo Experiments
To focus on understanding the miRNAmodulation and function
during infection, we searched for correlations between up- and
down-regulated miRNAs. We found some miRNAs differentially
expressed in infected THP-1 cells and plasma samples of ATL
patients (Table 2). The miR-548d-3p and miR-875 were
upregulated in self-healed patients and in vitro at 6 and 24 h
of incubation post-infection. Despite that, miR-211-5p and miR-
29b-3p were upregulated in self-healed patients, but down-
regulated at 6 h of incubation post-infection in vitro. Down-
regulated expression was observed for miR-29c-3p ex vivo,
showing similar modulation in the in vitro experiment at both
time points. Finally, miR-30e-5p was upregulated in vitro at 6
and 24 h of incubation post-infection and down-regulated in
plasma samples (Figures 2C and 3C).
miRNA Predicted Targets and Interactions
With Biological Pathways Related to
ATL Pathogenesis
We used Diana MiRPath 3.0 with TargetScan2 as the chosen
algorithm to predict miRNA/mRNA interactions, focusing on
miRNAs modulated in infected THP-1 cells. Among the
interactions predicted in the initial analysis using the Diana

















0001 M/19 Military Paudalho/PE Ulcerated 01 1.0 × 2.0 15 days Left leg + + ND +
0002 M/21 Military Paudalho/PE Ulcerated 01 0.5 × 0.5 15 days Right
flank
+ + – +
0003 M/22 Military Paudalho/PE Ulcerated 01 0.5 × 0.5 15 days Right
hand
+ – + +
0004 M/20 Military Paudalho/PE Ulcerated 01 0.6 × 0.6 1 month Right
hand
+ – – +
0005 M/18 Student Moreno/PE Ulcerated 01 1.5 × 1.5 15 days Left
Leg
+ + + +




















+ – – ND
0007 M/29 Machine
operator
Jaboatão/PE Ulcerated 01 4.0 × 3.0 9 months Left leg − + – ND
0008 M/30 Engineer Bezerros/PE Ulcerated 02 2.0 × 2.0 6 months Left leg − + – ND
0009 F/24 Housewife Moreno/PE Ulcerated 01 1.5 × 1.5 4 months Right
leg
+ + – ND
0010 M/21 Farmer Moreno/PE Ulcerated 01 2.0 × 2.0 3 months Right
thigh
− + + ND
M, male; F, female; L, left; R, right; PCR, polymerase chain reaction; IDRM, Montenegro skin test; ND, not done.
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platform, there were cytokines encoded by the TGFB2 and IL10
genes, MHC class II proteins (HLA-DPA1, HLA-DRB5, and
HLA-DOA) and genes related to signaling pathways (e.g.
MAPK1, MAP3K7, IRAK4) (Figure 4).
Further predictions made in MiEAA platform showed, in
more than one classification system (PANTHERDB,
WikiPathways, and KEGG), some pathways known to be
important in the parasite-host interaction that can be regulated
by the expressedmicroRNAs in L. braziliensis-infected THP-1 cells
(Figure 5A) and in self-cured patients plasma comparedwith active
patient sample (Figure 5B). Cytokine signaling pathways, such as
IFN-g, TNF-a, and TGF-b, are known to be involved in the
immune response against Leishmania. Also, signal transduction
pathways such as JAK-STAT and PI3K were putative targets of
differentially expressed miRNAs, as well as the VEGF, Wnt, and
HIF-1 pathways. There is also a potential interference of miRNAs
expressed in the oxidative stress pathway. Finally, the signaling
cascade activated by IGF receptors may be influenced by
the differentially expressed microRNAs. Searching predicted
pathways targeted by the circulating microRNAs present in
plasma, we observed the inflammation mediated by chemokines
and cytokines and the chemokine signaling pathways. Besides,
important pathways involved in B cell development like B cell
activation and mTOR signaling pathways were predicted.
Pathways involved in Th17 and Th2 differentiation and T cell
proliferation such as T cell activation, IL-4, IL-6, and IL-2 signaling
were evidenced.
Among various differentially expressed miRNAs, we selected
miR-548d-3p that was upregulated in patient plasma and L.
braziliensis-infected THP-1 cells and targets only two pathways
for further validation.
Effect of miR-548d-3p Inhibition on
Parasite Load in THP-1 Infection With
L. (V.) braziliensis
The function of miR548d-3p during L. braziliensis infection was
evaluated using 10 nM specific inhibitor or scrambled miRNA.
At both 6 and 24 h post-infection, a significant decrease was
observed in parasite load when miR-548d-3p was inhibited (P <
0.05), compared to transfection with scrambled RNA, negative
control (Figure 6A).
miR-548d-3p Inhibition on Chemokine
Production in L. (V.) braziliensis–Infected
THP-1 Cells
Inhibition of miR-548d-3p did not affect the production of CCL2
by infected THP-1 cells at 6 h p.i. but led to a >2-fold increase in
secretion of CCL2 at 24 h p/i/compared to both untreated
infected cells and cells treated with the scrambled RNA-
negative control (Figure 6B). In contrast, CCL5 production
appeared more susceptible to modulation by transfection of the
scrambled control RNA and use of the inhibitor tended to
normalize the production to that seen in untransfected cells
(Figure 6C). The production of CXCL8 and CXCL10 were not
significantly affected by the miR-548d-3p inhibitor in
comparison to untransfected cells but a small but significant
increase in CXCL10 was observed compared to the scrambled
inhibitor at 24 h p.i. (Figures 6D, E).
Chemokine Levels in Plasma of ATL
Patients
CCL2 was found at significantly higher concentration in plasma
samples of patients with active disease compared to self-healed




FIGURE 3 | Volcano plot of differential expression of miRNA in plasma of
cutaneous leishmaniasis patients. Volcano plot of differential expression of
miRNA in plasma samples of active disease patients (A) and self-healed
(B) compared to healthy individuals, and self-healed (C) compared to active
disease patients. Each dot represents one miRNA. Red dots indicate the up-
regulated miRNAs, and the blue dots represent the down-regulated miRNAs
(P < 0.05). Black dotted line corresponds to p=0.05, log 10. The relative up-
and down-regulation of miRNAs, expressed as boundaries of 2 or -2 of Fold
Regulation, respectively. P-value was determined based on two-tailed
Student’s t test. P < 0.05 (Student t test and Bonferroni correction).
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were decreased in self-healed cases compared to active cases
(Figures 7B, C). Significantly higher concentrations of CXCL9
(Figure 7D) and IP-10 (Figure 7E) were seen in self-healed
patients in relation to healthy individuals and patients with active
disease (P < 0.05).
DISCUSSION
Macrophages exert a dual role in the pathogenesis of CL,
being both host cell and also the main effector cell for
parasite clearance (Tomiotto-Pellissier et al., 2018). The disease
outcome depends on the interplay between Leishmania and the
host immune responses which govern these opposing
macrophage functions. Leishmania employ strategies to evade
the host immune response, including altering the miRNAs
expression (Lemaire et al., 2013; Muxel et al., 2017; Muxel
et al., 2018; Nunes et al., 2018; Fernandes et al., 2019; Paul
et al., 2020). In this context, having access to L. braziliensis-
infected active and self-healed CL patients, we searched for
differentially expressed miRNAs in plasma and in parallel
conducted an in vitro study using L. (V.) braziliensis infected-
human monocyte-derived THP-1 cells. With this approach, we
sought to attribute altered miRNA profiles to mechanisms of
disease pathogenesis.
Alterations of miRNA expression were seen in self-healed
patient samples compared with active cutaneous leishmaniasis
cases and healthy controls, the latter being indistinguishable by
miRNA profile. Thus, these data suggest that host cells from
individuals that cure without treatment are more active in
altering miRNA expression upon L. (V.) braziliensis infection,
although we cannot rule out at this preliminary stage in our
investigation whether this is confounded by other factors
unrelated to infection e.g., environmental exposure or host
genetics. Concerning environment, the patients were from
endemic areas, from nearby cities with similar climate and
environmental characteristics. Differentially expressed miRNAs
have been related to inflammatory chemokine levels, and this
may contribute to the self-healing nature of these patients. An
additional weakness of the study is that parasites from these
patients were not genotyped or functionally evaluated. This may
TABLE 2 | Set of miRNAs significantly expressed both in in vitro and ex vivo contexts.















miRNAs in bold, molecules modulated in similar ways in both experiments.
FIGURE 4 | Predicted interactions between the set of differentially expressed microRNAs in THP-1 cells after 6 and 24 h post infection. The genes on which they
are suggested to act in the Leishmaniasis pathway in humans are shown as seen in KEGG. miRNAs were classified into four groups according to their modulation
through time: down-regulated in 6 and 24 h (A), up-regulated on 6 h and down-regulated in 24 h (B), down-regulated in 6 h and up-regulated in 24 h (C) and up-
regulated in both timepoints (D).
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be important given that some strains of L. braziliensis are more
susceptible to oxidative stress than others, and induce lesions
with a higher tendency to spontaneous healing (Souza et al.,
2010; Sarkar et al., 2012). In addition, we have to consider a
proper balance between regulatory and pro-inflammatory
mediators, especially IFN-g and IL-10, that may differ
depending on the hosts background, important for the lesion
to heal (Gomes-Silva et al., 2007; de Assis Souza et al., 2013).
Evaluation of altered miRNA expression in vitro L. (V.)
braziliensis infected-human monocyte-derived THP-1 cells
showed a set of miRNAs also found altered in plasma
of leishmaniasis patients. In silico prediction of THP-1
expressed miRNA targets and interactions with biological
pathways suggested a link between the differentially expressed
miRNAs and altered expression targeted cytokine, chemokine,
and signaling pathways, signal transduction pathways, and others.
A total of 19 out of 84 miRNAs exhibited an altered in vitro
expression compared with non-infected THP-1 cells either at 6 or
24 h of incubation after infection, showing that Leishmania can
modulate these molecules in a temporally distinct manner during
the early stages of in vitro infection as seen by others (Guerfali et al.,
2008; Bazzoni et al., 2009; Lemaire et al., 2013). In the in-silico
predictions using DIANA miRPath 3.0, considering Leishmania
infection pathway, upregulated miR-195-5p at 6 h may target
tumor-necrosis factor receptor-associated factor 6 (TRAF6), an
important player in signal transduction of both the TNF receptor
(TNFR) superfamily and the interleukin-1 receptor (IL-1R). These
are crucial to ultimately activate transcription factors, such as
nuclear factor kappa B (NF-kB) and interferon-regulatory factor
(IRF), to induce immune and inflammatory responses (Ye et al.,
2002; Wang et al., 2010). In addition, two isoforms of miR-30
family, miR-30a-5p, and miR-30e-5p, were suggested to target
Interferon gamma receptor 2 (IFNGR2), Janus kinase 1 (JAK1),
Integrin subunit alpha 4 (ITGA4) genes throughout time. These
predicted interactions suggest participation in parasite control
mechanism and inflammatory process. Other important events of
the immune response such as Toll-like receptor signaling and
antigen presentation were also predicted to be compromised by
the influence of let-7i-5p, miR-130a-3p, miR-520d-3p, and two
isoforms of miR-302.
Other relevant pathways that are known to play a role in the
adaptive immune response in cutaneous leishmaniasis were
targeted by miRNAs identified exclusively in plasma samples
from self-healed patients compared with active disease subjects.
Pathways related to T and B cell activation including mTOR
pathway that can modulate B cell development (Limon and
Fruman, 2012; Iwata et al., 2017) were predicted. Cytokine
related pathways such as IL-2, IL-4, IL-6, and IL-9 were also
evidenced. These different pathways potentially targeted by
circulating microRNAs might reflect the diversity of cells
participating in the immune response in humans, in contrast
to exclusively monocyte/macrophage in vitro experiment.
A
B
FIGURE 5 | Predicted interactions between the set of differentially expressed microRNAs in THP-1 cells after 6 and 24 h post infection with L. braziliensis (A) and in
plasma samples from self-healed patients compared to active disease individuals (B) and the biological pathways related to inflammatory response on which they are
suggested to act according to MiEAA algorithms. In (B), pathways in red were predictably targeted by in vitro and ex vivo miRNA sets, while the others in blue were
evidenced only in miRNAs significantly quantified in plasma.
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Among altered miRNAs in the present study, other miRNAs
belonging to the same familywerepreviously analyzed inLeishmania
infection. The modulation of miR-29b, miR-29c, and miR-30e were
observed in L. amazonensis-infected murine macrophages (Muxel
et al., 2017;Muxel et al., 2018; Fernandes et al., 2019).Upregulationof
miR-29b was observed in L. major-infected human monocyte-
derived macrophages, whereas this miRNA was down-regulated in
L. donovani infection (Geraci et al., 2015). Stimulation of the
nucleotide-binding oligomerization domain containing 2 (NOD2)
induces miR-29 family upregulation, resulting in downregulation of
IL-12p40 without alteration to IL-6, TGF-b or IL-10 production (Yu
et al., 2002; Guo et al., 2012; Reveneau et al., 2012). However, NOD2-
stimulation increases the levels of IL-1b, IL-6, and IL-23 cytokines,
Nitric Oxide Synthase 2 (NOS2) expression and nitric oxide
(NO) production during Leishmania infection (Lima-Junior
et al., 2013).
We also searched for other biological pathways that could be
affected during Leishmania infection, and our predictions using
the MiEAA platform pointed to some involved in inflammation
and wound healing as follows. Also, our predictions highlighted
TNF, IFN-g, and TGF-b signaling pathways, cytokines with
respective proinflammatory and regulatory roles in Leishmania
infection (Souza et al., 2012; de Assis Souza et al., 2013; Souza
et al., 2016). The oxidative stress response pathway was also
revealed once reactive oxygen and nitrogen species (ROS and
RNS) produced during an inflammatory response are an
important part of host-defense strategies of organisms to kill
the parasite (Kocyigit et al., 2005).
Many characteristics of leishmanial lesions such as
microcirculation impairment, metabolic demand for leukocytes,
parasite proliferation, and secondary bacterial infection are
indicators of a hypoxic event in those lesions (Fraga et al., 2012).
Related to this condition, changes in miRNAs that regulate
Hypoxia-inducible factor 1 (HIF-1) activation in response to
hypoxia were also identified in silico. Other possible consequence
of a hypoxic, inflammatory microenvironment is the induction of
vascular remodeling via Vascular endothelial growth factor A/
Vascular endothelial growth factor receptor (VEGF-A/VEGFR)
expression by HIF-1 influence, which are elevated in the skin of
humans and mice infected with Leishmania parasites (Fraga et al.,
2012; Araujo and Giorgio, 2015). Differentially expressed miRNA
affecting VEGF were also observed in our data. Our in-silico
predictions also showed that some of the altered miRNAs targets
the IGF-I signaling pathway. The role of this hormone in
Leishmania infection has been long studied with pleiotropic effect
in innate and adaptive immune response and pathogenesis in
leishmaniases (Reis et al., 2021).
Cutaneous lesions are characterized by chronic inflammation
where concur activated CD69+ T cells (Diaz et al., 2002),





FIGURE 6 | Parasite load (number of amastigotes/100 cells) (A) and chemokine levels (pg/ml) (B–E) in L. (V.) braziliensis promastigote-infected THP-1 cells
transiently transfected with miR-548d-3p inhibitor at 6 and 24 h post-infection. One experiment was carried out by adding the miR-548d-3p inhibitor (10 nM) or
negative control (scrambled miRNA; 10 nM) with the transfection reagent diluted in RPMI medium or only RPMI medium (non-transfected cells) to wells containing
106 THP-1 adherent cells and maintained for 24 h at 37°C (5% CO2) then infected with L. (V.) braziliensis promastigotes. (A) * = P < 0.05 (one way ANOVA and
Student t test). MCP1/CCL2 (B), RANTES/CXCL5 (C), IL-8/CXCL8 (D), and IP-10/CXCL10 (E) concentrations were measured by flow-cytometry using the CBA kit.
(B–E) * = p <0.05 (Kruskal-Wallis and Bonferroni tests).
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granzyme A CD8+ cytotoxic T cells, CD4+ IFN-g–producing T
cells (Bourreau et al., 2009; Faria et al., 2009) and where higher
expression of gene sets related to the cytolytic pathway is
observed (Amorim et al., 2019). The influx of cells into the
lesion reflects the role of chemokines and one of miRNA seen
altered in vitro and patients’ plasma in the present study was
miR-548d-3p. miR-548d-3p and others from the same family
were reported related to wound healing and inflammation in
rheumatoid arthritis and Leishmania donovani infection (Wang
et al., 2018; Huang et al., 2020) thus we proceeded with
functional validation of the miR-548d-3p in L. braziliensis
infected-THP-1 cells. The miR-548 family is a larger and
poorly conserved, encompassing 69 human miR-548 genes
located in almost all human chromosomes (Liang et al., 2012).
Previous studies showed that miR-548d are processed from the
same encoded hairpin cluster of miR-548aa1 (GenBank ID
100500863) and that miR-548d-3p belongs to the cluster
family of hsa-miR-548-d1 (miRbase ID MI0003668)
(Cummins et al., 2006; Landgraf et al., 2007) transcribed
from negative strand of intronic region of ATPase family
AAA domain containing 2 (ATAD2, gene ID NM_014109.4)
gene located into chromosome 8 (search in miRIAD toll)
(Cummins et al., 2006). The transcription of miR-548d1 is
related to transcription of the ATAD2 gene, as observed upon
glucocorticoid stimulation (Rainer et al., 2009). This information
showed the complex changes in miRNA/miRtron expression
regulation upon distinct stimuli. ATAD2 has a ATP-binding site
and ATPase activity, regulating the assembly of protein
complexes (Morozumi et al., 2016), as CREB-binding promoter
region or regulating histone hyperacetylation (Koo et al., 2016;
Lazarchuk et al., 2020), suggesting the ATAD2/miR-548d can
alter gene transcription during infection. ATAD2 inhibits the
expression of vascular endothelial growth factor A (VEGFA) by
altering miR-520a levels (Hong et al., 2018), linking miR-548d
expression to modulation of other miRNAs. Also, ATAD2 can be
a target of miRNAs, including miRNAs modulated during
Leishmania infection including molecules described in our
study such as miR-302, miR-373, and miR-93 (Bragato et al.,
2018; Fernandes et al., 2019; Kumar et al., 2020).
miR-548d-3p was shown to enhance cell proliferation and
inhibit apoptosis in breast cancer cells (Song et al., 2016),
suggesting a possible role in inhibition of apoptosis seen in L.
donovani-infected macrophages (Moore and Matlashewski,
1994). The miR-548 family can regulate expression of High
mobility group box1 (HMBG1) a non-histone nuclear protein,
a potent stimulator of tissue damage and inflammation through
expression of pro-inflammatory cytokines (Martinotti et al.,





FIGURE 7 | Chemokine concentration (pg/ml) in plasma of cutaneous leishmaniasis patients and controls. MCP1/CCL2 (A), RANTES/CXCL5 (B), IL-8/CXCL8 (C),
MIG/CXCL9 (D), and IP-10/CXCL10 (E) concentrations were measured by flow-cytometry using the CBA kit. * = p < 0.05 (Kruskal-Wallis and Bonferroni tests). N =5
patients and controls per group.
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in healing and inflammatory processes. In post-burn wound
healing, the vascular endothelial growth factor-A (VEGFA) a key
factor involved in the wound healing process was shown to likely
be targeted by miR-548d-3p (Huang et al., 2020). In rheumatoid
arthritis, an autoimmune inflammatory disease, another member
of the miR-548 family, miR-548a-3p, was significantly down-
regulated in serum samples targeting Toll-like receptor 4/nuclear
factor kappa B (TLR4/NF-kappaB) signaling pathway (Wang
et al., 2018). In THP-1 cells infected with promastigotes isolates
from post-kala-azar dermal leishmaniasis, other members of the
548-miRNA family, miR-548at-5p, miR-548t-3p, were
upregulated when compared to THP-1 cells infected with
promastigotes isolated from visceral leishmaniasis patients
(Kumar et al., 2020).
Importantly, miR-548d-3p was induced in both self-healed
leishmaniasis patient samples and in vitro L. braziliensis-infected
THP-1 cells. Because the miR-548-3p was found in patients’
plasma, it is likely that it is secreted by L. braziliensis-infected
THP-1 cells, an aspect deserving further studies. It is known that
THP-1 cell line can actively secrete microvesicles and exosomes
that may contain miRNAs, such as miR-150 (Zhang et al., 2010)
and miR‐103‐3p (Chen et al., 2020). Further, the content of
microvesicles and exosomes may be modified by inflammatory
conditions, infections including Leishmania, apoptosis, etc
(Silverman et al., 2010; Baxter et al., 2019; Yao et al., 2019).
Inhibiting miR-548d-3p in THP-1 cells we observed a
decrease in parasite load, and an increase in the production of
MCP1/CCL2, RANTES/CCL5, and IP-10/CXCL10. In parallel,
in plasma of self-healed patients, MCP1/CCL2, RANTES/CCL5,
and IL-8/CXCL8 were decreased but increased MIG/CXCL9 and
IP-10/CXCL10. We should be cautious to relate the in vitro
experimental data to the evaluation in plasma. However, we
observe a dichotomy impact of miR-548d, when upregulated in
the early stage of in vitro infection of THP-1 derived monocytes
by L. braziliensis (6–24 h) that is apparently reducing MCP-1
and RANTES at the infection site, contributing to the control of
local inflammatory response, but at the same time, it is enabling
parasite growth subverting the inflammatory response and lesion
wound healing. These findings, considering the possibility of
secretion of miR548d-3p by macrophages, are in line with the
upregulated miR548d-3p found in the self-healed plasma
patients that may reduce the MCP-1 and RANTES at systemic
levels, contributing positively to wound healing modulating the
inflammation. High IP-10 and MIG secretion in self-healed
patients suggests that the miR-548-3p is not able to control the
secretion of these cytokines. Previously, we observed higher
levels of IP-10 and MIG, IFN-g, and TNF in active and self-
healed cutaneous leishmaniasis regulating parasite growth
control (Souza et al., 2012; de Assis Souza et al., 2013).
Other studies have reported the role of these chemokines in
cutaneous leishmaniasis. RANTES/CCL5, together with KC/
CXCL1 and MIP-2/CXCL2 (Ohmori and Hamilton, 1994;
Lebovic et al., 2001) participate in neutrophil, monocyte, and
lymphocyte recruitment to inflammatory focus and interfere in
the persistence of cutaneous leishmaniasis lesions (Teixeira et al.,
2005; Costa-Silva et al., 2014). In experimental cutaneous
leishmaniasis, the upregulation of miR-294 regulated Ccl2/Mcp-1
mRNA levels and infectivity in L. amazonensis infected BALB/c
bone marrow-derived macrophages (Fernandes et al., 2019).
Similarly, the downregulation of chemokines CCL2, CCL5,
CXCL10, CXCL11, and CXCL12 was seen with upregulation of
let-7a, miR-25, miR-26a, miR-132, miR-140, miR-146a, and miR-
155 inL.major-infectedhumanmacrophages (Guerfali et al., 2008).
miRNAs are promising tools for diagnosis, treatment, and
prognostic markers. Product for diagnosis is a reality mainly for
cancers. No miRNA-based therapeutic formulations like miRNA
mimics and antagomirs have reached the pharmaceutical
breakthrough, but some are currently in clinical trials. In CL
caused by L. braziliensis, miR-361-3p was appointed as a
prognostic marker related to therapeutic failure. The miR-
548d-3p evaluated in the present study was shown to exert
tumor-suppressive effects in osteosarcoma cells and proposed
as a therapeutic tool for osteosarcoma (Chen et al., 2019). Based
on our findings, further studies are warranted to more clearly
establish a role for miR-548d-3p as a prognostic marker and
therapeutic target in cutaneous leishmaniasis.
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inhibitor or negative control (scrambled miRNA) transiently transfected on parasite
load (number of amastigotes/100 cells) in L. (V.) braziliensis promastigote-infected
THP-1 cells at 6 h (A) and 24 h (B) post-infection. The experiment was carried out
by adding the synthetic molecules at 3nM, 10nM or 30nM with the transfection
reagent diluted in RPMI medium or only RPMI medium (non-transfected cells) to
wells containing 106 THP-1 adherent cells and maintained for 24 h at 37°C (5%
CO2) then infected with L. (V.) braziliensis promastigotes. (A) * = P < 0.05 (one way
ANOVA and student t test).
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